Universidad Peruana Cayetano Heredia

Scoping review of measures of treatment burden in patients with multimorbidity: Advancements and current gaps.

Mostrar el registro sencillo del ítem

dc.contributor.author Mendoza Quispe, Daniel Enrique
dc.contributor.author Pérez León Quinoso, Silvana Patricia
dc.contributor.author Alarcon-Ruiz, Christoper A.
dc.contributor.author Gaspar, Andrea
dc.contributor.author Cuba Fuentes, María Sofia
dc.contributor.author Zunt, Joseph R.
dc.contributor.author Montori, Victor M.
dc.contributor.author Bazo-Alvarez, Juan Carlos
dc.contributor.author Miranda, J. Jaime
dc.date.accessioned 2023-06-12T16:25:55Z
dc.date.available 2023-06-12T16:25:55Z
dc.date.issued 2023
dc.identifier.uri https://hdl.handle.net/20.500.12866/13614
dc.description.abstract OBJECTIVE: To identify, assess, and summarize the measures to assess burden of treatment in patients with multimorbidity (BoT-MMs) and their measurement properties. STUDY DESIGN AND SETTING: MEDLINE via PubMed was searched from inception until May 2021. Independent reviewers extracted data from studies in which BoT-MMs were developed, validated, or reported as used, including an assessment of their measurement properties (e.g., validity and reliability) using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN). RESULTS: Eight BoT-MMs were identified across 72 studies. Most studies were performed in English (68%), in high-income countries (90%), without noting urban-rural setting (90%). No BoT-MMs had both sufficient content validity and internal consistency; BoT-MMs had some measurement properties either insufficient or uncertain (e.g., responsiveness). Other frequent limitations of BoT-MMs included absent recall time, presence of floor effects, and unclear rationale for categorizing and interpreting raw scores. CONCLUSION: The evidence needed for use of extant BoT-MMs in patients with multimorbidity remains insufficiently developed, including that of suitability on their development, measurement properties, interpretability of scores, and use in low-resource settings. This review summarizes this evidence and identifies issues needing attention for using BoT-MMs in research and clinical practice. en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartofseries Journal of Clinical Epidemiology
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Chronic disease en_US
dc.subject Multimorbidity en_US
dc.subject Cost of illness en_US
dc.subject Surveys and questionnaires en_US
dc.subject Patient Reported Outcome Measures en_US
dc.subject Scoping review en_US
dc.subject.mesh Enfermedad Crónica
dc.subject.mesh Multimorbilidad
dc.subject.mesh Costo de Enfermedad
dc.subject.mesh Encuestas y Cuestionarios
dc.subject.mesh Medición de Resultados Informados por el Paciente
dc.subject.mesh Revisión
dc.title Scoping review of measures of treatment burden in patients with multimorbidity: Advancements and current gaps. en_US
dc.type info:eu-repo/semantics/review
dc.identifier.doi https://doi.org/10.1016/j.jclinepi.2023.05.013
dc.relation.issn 1878-5921


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas